United States: European Competition Law Newsletter – January 2014

Last Updated: January 6 2014
Article by Matthew Hall and Alessandro Nucara

UK Office of Fair Trading Fines Show Risk for Small Companies and Short-Term Cartels

During December 2013, two UK Office of Fair Trading (OFT) cases showed once again that small companies can be fined for cartel infringements in the EU and also that short-term cartels will not be spared.

In the first decision, announced on 6 December 2013, the OFT fined three companies for engaging in collusive tendering concerning the supply and installation of access control and alarm systems to retirement properties in the UK. A fourth party escaped fines since it was the whistleblower (first in) under the OFT's leniency programme. The combined value of the at least 65 tenders involved amounted to only around GBP1.4 million. The total fines on the small companies involved amounted to only around GBP50,000, with one party fined under GBP2,000.

In the second case, the OFT announced on 12 December 2013 that a prescription medicine supplier, Hamsard, had agreed to pay a fine of GBP388,000 for entering into a market-sharing agreement with competitor Celesio in the UK. Celesio escaped a fine entirely since it was the whistleblower. Hamsard's fine was reduced since it also used the OFT's leniency programme (but as second in) and cooperated with the OFT under its settlement procedure, including by agreeing to pay the fine. This was a short-term cartel, running only between May and November 2011.

The fines in these cases were relatively small but it is clear that being involved in a cartel remains a key risk area for all businesses. Apart from fines, cartel decisions inevitably give rise to reputational damage and these days it is almost inevitable that customers will bring private actions for damages. Competition compliance programmes remain very important, whatever the size of a business. Apart from reducing the risk of cartel (or other anti-competitive) activity in the first place, a key benefit is the possibility of taking advantage of leniency if the programme catches a cartel.

EC Publishes Latest Pharma Patent Settlement Survey, But Legal Position Still Unclear

The European Commission's (EC) latest report on pharmaceutical patent settlement agreements in the EEA (the EU plus three other countries), covering 2012, was published on 9 December 2013. The EC started these reports after its 2009 competition inquiry into the pharmaceutical sector, which identified settlements that limit generic entry and provide at the same time for a value transfer from the originator to the generic company as potentially raising competition concerns.

The headline finding in the report is that, compared with previous years, the number of such potentially problematic settlement agreements has continued to fall, in 2012 accounting for around 7% of all patent settlements in the pharmaceutical sector in the EEA.

The EC says that this shows the industry's increased awareness of potentially problematic practices. This may or may not be the case, but in any event this area of law remains unclear despite these reports and the EC's June 2013 Lundbeck decision. In that case, the EC imposed a fine of EUR93.8 million on Danish pharmaceutical company Lundbeck and fines totalling EUR52.2 million on several producers of generic medicines for agreeing to delay the market entry of cheaper generic versions of citalopram, a blockbuster antidepressant.

The EC's very strict approach in that case has been appealed to the EU General Court (GC) and the correct legal position will not be known until the court opines. Meanwhile, legal uncertainty limits the appetite of originators and generics to negotiate patent settlement agreements and indeed probably reduces the likelihood that generic suppliers will challenge patents in the first place (which could in turn skew the findings of the EC's monitoring reports going forward).

It Doesn't Matter What You Call It; "Co-promotion" Agreement Fined as a Cartel

On 10 December 2013, the EC imposed fines of EUR10.8 million on Johnson & Johnson (J&J) and EUR5.5 million on Novartis for an "intolerable" agreement to share "monopoly profits" on a pharmaceutical product in the Netherlands. The agreement between the companies was termed a "co-promotion" agreement but was seen and fined as a cartel.

The case concerned fentanyl, a painkiller produced and sold by J&J. In 2005, Novartis was preparing to sell its own generic version of fentanyl, which was no longer protected in the Netherlands. However, according to the EC, instead of competing against each other, the companies agreed that Novartis would abstain from entering the Dutch market in exchange for "a part of [Johnson & Johnson's] cake". They therefore concluded a so-called "co-promotion agreement" which gave Novartis strong incentives not to enter the market.

In particular, under the pretext of "co-promotion", J&J would make monthly payments to Novartis for as long as there was no generic on the market. Although this case arose in the pharmaceutical sector and concerned generics, this was not a pharmaceutical "patent settlement" case. It was simply a situation in which one party paid another to keep a competing product out of the market. A similar scenario in any other sector would be viewed and treated in exactly the same way.

EU Court Accepts High Market Shares Need Not be Definitive in Tech Deals

An attempt to overturn the EC's 2011 clearance of Microsoft's acquisition of Skype was rejected by the GC in an 11 December 2013 ruling. The GC ruled that, despite Microsoft's very high post-transaction share of a particular market (80-90% of video communications on Windows-based PCs), the EC had been correct to clear the transaction unconditionally.

The GC agreed that even this market share level was not indicative of market power given the particular characteristics of the market in question, which is marked by short innovation cycles and products which are free. Therefore, if Microsoft started to make PC users pay for such a product, this would only encourage them to switch to other providers that continued to offer their services free of charge.

This judgment is very encouraging for parties considering mergers, acquisitions or joint ventures in similar fast-moving markets. If it can be shown that competitors and potential competitors remain able to win customers either through existing or new products, then very high market shares won't be a bar to clearance. The EC, responding to the judgment, emphasized this point by stating that it "...confirms the [EC]'s assessment of new markets and technologies... The [EC]'s decision to clear the transaction did not put the development of innovative products and services at risk. The [EC] will continue to ensure that competition in nascent and fast evolving markets is maintained." This is similar to the U.S. approach, although is not necessarily reflected in other jurisdictions around the world.

State Aid to Professional Football Clubs: Any Economic Advantage Can Amount to State Aid

For the second time this year, the EC has launched an investigation into alleged illegal aid provided by an EU Member State to professional football clubs. On 18 December 2013, the EC announced that it is looking into various support measures granted by Spain to three clubs without approval from the EC. The measures are tax advantages granted to Real Madrid, Barcelona, Athletic Club Bilbao and Club Atletico Osasuna, the transfer of a significant piece of land from the City of Madrid to Real Madrid, and State guarantees issued in favour of Valencia, Hercules and Elche which were used to finance those clubs when they were in financial difficulties. The EC stated "professional football clubs should finance their running costs and investments with sound financial management rather than at the expense of the taxpayer". Third parties are invited to comment and if the investigation confirms the existence of the allegedly illegal aid, the EC will order Spain to recover from the clubs the value of the benefit plus interest.

The case provides a reminder that, when benefiting from State support (in any form), companies should always ensure that it is State aid compliant. Otherwise, there is a risk of it being recovered later. At the same time, public bodies have an interest in assessing the State aid compliance of their support measures at the outset, since they can be sued for damages (for example by the beneficiaries' competitors) if they grant illegal aid.

Additional European competition law news coverage can be found in our news section.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions